The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ranibizumab Market Research Report 2025
Synopsis
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
The global Ranibizumab market was valued at US$ 3449.6 million in 2023 and is anticipated to reach US$ 1647.3 million by 2030, witnessing a CAGR of -9.9% during the forecast period 2024-2030.
Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
This report aims to provide a comprehensive presentation of the global market for Ranibizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranibizumab.
Report Scope
The Ranibizumab market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ranibizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranibizumab companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Novartis
Segment by Type
Glass Vial
Prefilled Syringe
Segment by Application
Wet AMD
Complications of Diabetes
RVO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranibizumab companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
The global Ranibizumab market was valued at US$ 3449.6 million in 2023 and is anticipated to reach US$ 1647.3 million by 2030, witnessing a CAGR of -9.9% during the forecast period 2024-2030.
Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
This report aims to provide a comprehensive presentation of the global market for Ranibizumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranibizumab.
Report Scope
The Ranibizumab market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ranibizumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranibizumab companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Novartis
Segment by Type
Glass Vial
Prefilled Syringe
Segment by Application
Wet AMD
Complications of Diabetes
RVO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ranibizumab companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Glass Vial
1.2.3 Prefilled Syringe
1.3 Market by Application
1.3.1 Global Ranibizumab Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Wet AMD
1.3.3 Complications of Diabetes
1.3.4 RVO
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ranibizumab Market Perspective (2019-2030)
2.2 Ranibizumab Growth Trends by Region
2.2.1 Global Ranibizumab Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ranibizumab Historic Market Size by Region (2019-2024)
2.2.3 Ranibizumab Forecasted Market Size by Region (2025-2030)
2.3 Ranibizumab Market Dynamics
2.3.1 Ranibizumab Industry Trends
2.3.2 Ranibizumab Market Drivers
2.3.3 Ranibizumab Market Challenges
2.3.4 Ranibizumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ranibizumab Players by Revenue
3.1.1 Global Top Ranibizumab Players by Revenue (2019-2024)
3.1.2 Global Ranibizumab Revenue Market Share by Players (2019-2024)
3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ranibizumab Revenue
3.4 Global Ranibizumab Market Concentration Ratio
3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2023
3.5 Ranibizumab Key Players Head office and Area Served
3.6 Key Players Ranibizumab Product Solution and Service
3.7 Date of Enter into Ranibizumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ranibizumab Breakdown Data by Type
4.1 Global Ranibizumab Historic Market Size by Type (2019-2024)
4.2 Global Ranibizumab Forecasted Market Size by Type (2025-2030)
5 Ranibizumab Breakdown Data by Application
5.1 Global Ranibizumab Historic Market Size by Application (2019-2024)
5.2 Global Ranibizumab Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ranibizumab Market Size (2019-2030)
6.2 North America Ranibizumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ranibizumab Market Size by Country (2019-2024)
6.4 North America Ranibizumab Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ranibizumab Market Size (2019-2030)
7.2 Europe Ranibizumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ranibizumab Market Size by Country (2019-2024)
7.4 Europe Ranibizumab Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ranibizumab Market Size (2019-2030)
8.2 Asia-Pacific Ranibizumab Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ranibizumab Market Size by Region (2019-2024)
8.4 Asia-Pacific Ranibizumab Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ranibizumab Market Size (2019-2030)
9.2 Latin America Ranibizumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ranibizumab Market Size by Country (2019-2024)
9.4 Latin America Ranibizumab Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ranibizumab Market Size (2019-2030)
10.2 Middle East & Africa Ranibizumab Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ranibizumab Market Size by Country (2019-2024)
10.4 Middle East & Africa Ranibizumab Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Ranibizumab Introduction
11.1.4 Roche Revenue in Ranibizumab Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Ranibizumab Introduction
11.2.4 Novartis Revenue in Ranibizumab Business (2019-2024)
11.2.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Glass Vial
Table 3. Key Players of Prefilled Syringe
Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Ranibizumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Ranibizumab Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Ranibizumab Market Share by Region (2019-2024)
Table 8. Global Ranibizumab Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Ranibizumab Market Share by Region (2025-2030)
Table 10. Ranibizumab Market Trends
Table 11. Ranibizumab Market Drivers
Table 12. Ranibizumab Market Challenges
Table 13. Ranibizumab Market Restraints
Table 14. Global Ranibizumab Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Ranibizumab Market Share by Players (2019-2024)
Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2023)
Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ranibizumab Product Solution and Service
Table 21. Date of Enter into Ranibizumab Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ranibizumab Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Ranibizumab Revenue Market Share by Type (2019-2024)
Table 25. Global Ranibizumab Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Ranibizumab Revenue Market Share by Type (2025-2030)
Table 27. Global Ranibizumab Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Ranibizumab Revenue Market Share by Application (2019-2024)
Table 29. Global Ranibizumab Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Ranibizumab Revenue Market Share by Application (2025-2030)
Table 31. North America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Ranibizumab Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Ranibizumab Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Ranibizumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Ranibizumab Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Ranibizumab Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Ranibizumab Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Ranibizumab Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Ranibizumab Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ranibizumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Ranibizumab Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Ranibizumab Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Ranibizumab Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Ranibizumab Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Ranibizumab Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Ranibizumab Product
Table 49. Roche Revenue in Ranibizumab Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Ranibizumab Product
Table 54. Novartis Revenue in Ranibizumab Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ranibizumab Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ranibizumab Market Share by Type: 2023 VS 2030
Figure 3. Glass Vial Features
Figure 4. Prefilled Syringe Features
Figure 5. Global Ranibizumab Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Ranibizumab Market Share by Application: 2023 VS 2030
Figure 7. Wet AMD Case Studies
Figure 8. Complications of Diabetes Case Studies
Figure 9. RVO Case Studies
Figure 10. Others Case Studies
Figure 11. Ranibizumab Report Years Considered
Figure 12. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Ranibizumab Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Ranibizumab Market Share by Region: 2023 VS 2030
Figure 15. Global Ranibizumab Market Share by Players in 2023
Figure 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2023
Figure 18. North America Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Ranibizumab Market Share by Country (2019-2030)
Figure 20. United States Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Ranibizumab Market Share by Country (2019-2030)
Figure 24. Germany Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Ranibizumab Market Share by Region (2019-2030)
Figure 32. China Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Ranibizumab Market Share by Country (2019-2030)
Figure 40. Mexico Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Ranibizumab Market Share by Country (2019-2030)
Figure 44. Turkey Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Ranibizumab Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Ranibizumab Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Ranibizumab Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
